Clear All
12611 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
00703-4852-11 00703-4852 Fludarabine phosphate Fludarabine phosphate 25.0 mg/mL Chemotherapy Antimetabolite Purine Analog Intravenous May 1, 2004 Jan 31, 2018 No Longer Used
67457-0617-30 67457-0617 GEMCITABINE HYDROCHLORIDE Gemcitabine 1.0 g/26.3mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Dec 18, 2017 In Use
25021-0201-10 25021-0201 Mesna Mesna 100.0 mg/mL Ancillary Therapy Chemoprotective Detoxifying Agent Intravenous Dec 1, 2010 In Use
00015-3072-97 00015-3072 Cisplatin Platinol Chemotherapy Alkylating Agent Platinum Compound Intravenous Jan 1, 2005 Jun 15, 2014 No Longer Used
82449-0231-01 82449-0231 FOSAPREPITANT DIMEGLUMINE FOCINVEZ 150.0 mg/50mL Ancillary Therapy Antiemetic Substance P/Neurokinin 1 Intravenous Jun 26, 2024 In Use
46708-0678-08 46708-0678 Docetaxel Docetaxel 10.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Feb 28, 2023 In Use
00009-0112-05 00009-0112 Irinotecan hydrochloride Camptosar 20.0 mg/mL Chemotherapy Topoisomerase I Inhibitor Camptothecin Analogs Intravenous Dec 30, 2024 In Use
66758-0047-03 66758-0047 Carboplatin Carboplatin 10.0 mg/mL Chemotherapy Alkylating Agent Platinum Compound Intravenous Jan 31, 2010 Jul 19, 2015 In Use
83107-0030-02 83107-0030 Amifostine Ethyol 500.0 mg/10mL Ancillary Therapy Chemoprotective Detoxifying Agent Intravenous Mar 16, 2026 In Use
70121-1755-01 70121-1755 bevacizumab-maly ALYMSYS 400.0 mg/16mL Immunotherapy Monoclonal Antibody VEGF Intravenous Apr 15, 2022 Oct 31, 2028 In Use
44567-0504-01 44567-0504 Paclitaxel Paclitaxel 6.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Jul 11, 2013 Apr 30, 2022 No Longer Used
63323-0650-27 63323-0650 Oxaliplatin Oxaliplatin Chemotherapy Alkylating Agent Platinum Compound Intravenous May 30, 2012 May 21, 2015 No Longer Used
83831-0119-01 83831-0119 Cyclophosphamide Frindovyx 500.0 mg/mL Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Mar 19, 2025 In Use
80978-0111-06 80978-0111 Nelarabine injection NELARABINE 250.0 mg/50mL Chemotherapy Antimetabolite Purine Analog Intravenous Apr 12, 2023 In Use
82143-0001-01 82143-0001 Bevacizumab Avzivi 100.0 mg/4mL Immunotherapy Monoclonal Antibody VEGFR Intravenous Jan 1, 2025 In Use
00703-4805-03 00703-4805 Mesna Mesna 100.0 mg/mL Ancillary Therapy Chemoprotective Detoxifying Agent Intravenous May 1, 2002 Jan 31, 2013 No Longer Used
00517-0746-01 00517-0746 Pamidronate Disodium Pamidronate Disodium 9.0 mg/mL Ancillary Therapy Bisphosphonate Intravenous Aug 9, 2010 Nov 1, 2012 No Longer Used
14789-0126-05 14789-0126 Cyclophosphamide Cyclophosphamide 200.0 mg/mL Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Mar 30, 2026 In Use
55390-0805-10 55390-0805 Daunorubicin Hydrochloride Daunorubicin Hydrochloride Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Jun 28, 1996 Apr 30, 2013 No Longer Used
69171-0398-01 69171-0398 Irinotecan Hydrochloride Onivyde 4.3 mg/mL Chemotherapy Topoisomerase I Inhibitor Camptothecin Analogs Intravenous Oct 22, 2015 Sep 30, 2019 No Longer Used
64679-0186-01 64679-0186 Zoledronic Acid Zoledronic Acid 4.0 mg/5mL Ancillary Therapy Bisphosphonate Intravenous Mar 2, 2013 In Use
00003-3772-11 00003-3772 Nivolumab Opdivo 10.0 mg/mL Immunotherapy Checkpoint Inhibitor PD-1 Intravenous Dec 22, 2014 In Use
63759-3029-01 63759-3029 gemcitabine GEMCITABINE 1.0 g/1 Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Jun 19, 2019 In Use
55513-0224-21 55513-0224 Rituximab-arrx Riabni 100.0 mg/10mL Immunotherapy Monoclonal Antibody CD20 Intravenous Jul 21, 2025 In Use
00310-4715-11 00310-4715 IV Solution Stabilizer for Lumoxiti IV Solution Stabilizer for Lumoxiti 6.5 mg/mL Ancillary Therapy Excipient Intravenous Oct 24, 2018 In Use

Found 12611 results — Export these results